The peptides selected for cancer vaccine development can be classified in two main type: tumor-associated antigens (TAAs) and tumor-specific antigens (TSAs), which are captured, internalized, processed and presented by antigen-presenting cells (APCs) to cell-mediated immunity
10.1002/anie.201103754 47 LiY.YangM.HuangY.SongX.LiuL.ChenP
This compound must not be consumed, injected, applied topically, or used for therapeutic or diagnostic purposes
Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D-aspartate receptors mediated by Src kinase
Marketing materials for Minnesota's DSNPs can be jointly reviewed by the state and CMS within the same timeframe because all DSNPs in that state are in single-plan contracts
Is liposomal glutathione better than oral forms